Betacel

Last updated

Betacel is considered to be the first commercially successful betavoltaic battery. [1] [2] [3] It was developed in the early 1970s by Larry C. Olsen at the American corporation McDonnell Douglas, using the radioisotope Promethium-147 as the beta-electron source coupled to silicon semiconductor cells. This power source was incorporated in the Betacel-Biotronik heart pacemaker. The device was not widely adopted because of its limited lifespan and doubts over the use of radioactive material.

Contents

Development

The betavoltaic program along with the development of the Betacel was led by Dr. Olsen and a team of researchers at Donald W. Douglas Laboratories (DWDL), McDonnell Douglas Corporation, in the early 1970s. [4] As the first (and only) viable betavoltaic power source ever developed, it was immediately used to power heart pacemakers. Betacel powered cardiac pacemakers were implanted in numerous patients in the 1970s. Biotronik GmbH & Co., Ingenieurburo, Berlin, adapted its chemical battery-powered pacemakers to accept the promethium-fueled Betacel battery. The Betacel powered Biotronik pacemakers were considered to have useful lives of 7 to 10 years. [5] Clinical investigation of the Betacel-Biotronik pacemaker began in Europe in 1972 and was extended to the United States under State of Washington license in 1973. By early 1973, over 60 implanted Betacel-Biotronik pacemakers were being monitored as part of the clinical investigation. [3] [6] By mid-1974, the USAEC had authorized the licensing in the United States of a Clinical Investigation Program that allowed the implantation of 50 Betacel-Biotronik pacemakers per month in major clinics in the U.S. [7]

Original technology

Betacels utilized Pm-147 beta sources that were combined with custom designed silicon p-n junctions. Operational configurations involved stacking unidirectional sources with Si p-n junctions in a series arrangement. The power output of the Betacel was approximately 400 microWatts. The power density of the battery was approximately 0.025 milliWatts per cubic centimeter. The battery itself was approximately one cubic inch in volume (16 cm3). Most of the volume was used for shielding, to contain the gamma radiation that was emitted from the Pm-146 contaminant within the Pm-147. [8]

These Betacel batteries presented an efficiency of approximately 4%. However, higher efficiency devices were in the development process utilizing bidirectional beta sources. These bi-directional source devices would have yielded efficiencies approaching 8%. Unfortunately, these higher efficiency devices were never realized since pacemaker manufacturers focused on the use of lithium-ion batteries which did not utilize radioactive material, and could power pacemakers for 5 to 7 years.

Although previous betavoltaic devices degraded rapidly due to radiation damage, the Betacel showed no deleterious effects from radiation. The power levels decreased as expected. In particular, the battery power decreased exponentially with a half-life of 2.62 years, the same as that for Pm-147.

Limitations and demise

Pm-147 is not an ideal source since the half life is only 2.62 years and the contaminant Pm-146 emits gamma rays that require batteries to be well shielded. The material is toxic and not readily available. Moreover, at the time there was a certain stigma associated with the use of nuclear power and radioactive materials: the public was genuinely fearful and leery of any nuclear technology. This stigma, combined with advances in (and the lower cost of) lithium-ion battery technology, eventually overshadowed aspirations of a more lucrative future for the Betacel, relegating betavoltaic batteries to the realm of academic research in the years that immediately followed.

Later developments in betavoltaic technology

The Betacel did not last but it provided a foundation for future betavoltaic technology research and sparked a resurgence of interest in betavoltaic power generation. Other sources such as tritium have been considered and implemented in the development of betavoltaic batteries. Between 2001 and 2010, four commercial companies (City Labs, Inc., BetaBatt Inc., Qynergy, Inc. and Widetronix, Inc.) have ventured into betavoltaic power cell development, while university research on the subject is still actively being conducted. Rapid advances in semiconductor and materials science technology, integrated circuit design and fabrication, and micro- / nano-scale microelectromechanical systems (MEMS), have converged to the extent that extremely small devices with diminutive power requirements are becoming more and more routine. These devices are ideally suited for betavoltaic power sources that can easily and safely offer nanoWatt-to-microWatt power levels with enduring 20-year lifetimes.

Related Research Articles

Promethium Chemical element with atomic number 61

Promethium is a chemical element with the symbol Pm and atomic number 61. All of its isotopes are radioactive; it is extremely rare, with only about 500–600 grams naturally occurring in Earth's crust at any given time. Promethium is one of only two radioactive elements that are followed in the periodic table by elements with stable forms, the other being technetium. Chemically, promethium is a lanthanide. Promethium shows only one stable oxidation state of +3.

Artificial cardiac pacemaker

A cardiac pacemaker, is a medical device that generates electrical impulses delivered by electrodes to cause the heart muscle chambers to contract and therefore pump blood; by doing so this device replaces and/or regulates the function of the electrical conduction system of the heart.

Radioisotope thermoelectric generator A type of electric generator

A radioisotope thermoelectric generator is a type of nuclear battery that uses an array of thermocouples to convert the heat released by the decay of a suitable radioactive material into electricity by the Seebeck effect. This type of generator has no moving parts.

Implantable cardioverter-defibrillator Device implantable inside the body, able to perform cardioversion, defibrillation, and (in modern versions) pacing of the heart

An implantable cardioverter-defibrillator (ICD) or automated implantable cardioverter defibrillator (AICD) is a device implantable inside the body, able to perform cardioversion, defibrillation, and pacing of the heart. The device is therefore capable of correcting most life-threatening cardiac arrhythmias. The ICD is the first-line treatment and prophylactic therapy for patients at risk for sudden cardiac death due to ventricular fibrillation and ventricular tachycardia. Current devices can be programmed to detect abnormal heart rhythms and deliver therapy via programmable antitachycardia pacing in addition to low-energy and high-energy shocks.

Medtronic plc is an American-Irish registered medical device company that primarily operates in the United States. Medtronic has an operational and executive headquarters in Fridley, Minnesota in the US. In 2015, Medtronic acquired Irish–tax registered Covidien, in the largest U.S. corporate tax inversion in history, which enabled Medtronic to move its legal registration from the U.S. to Ireland. Medtronic operates in 140 countries and employs over 104,950 people.

Energy harvesting is the process by which energy is derived from external sources, captured, and stored for small, wireless autonomous devices, like those used in wearable electronics and wireless sensor networks.

An atomic battery, nuclear battery, radioisotope battery or radioisotope generator is a device which uses energy from the decay of a radioactive isotope to generate electricity. Like nuclear reactors, they generate electricity from nuclear energy, but differ in that they do not use a chain reaction. Although commonly called batteries, they are technically not electrochemical and cannot be charged or recharged. In comparison they are very costly, but have an extremely long life and high energy density, and so they are mainly used as power sources for equipment that must operate unattended for long periods of time, such as spacecraft, pacemakers, underwater systems and automated scientific stations in remote parts of the world.

A betavoltaic device is a type of nuclear battery which generates electric current from beta particles (electrons) emitted from a radioactive source, using semiconductor junctions. A common source used is the hydrogen isotope tritium. Unlike most nuclear power sources which use nuclear radiation to generate heat which then is used to generate electricity, betavoltaic devices use a non-thermal conversion process, converting the electron-hole pairs produced by the ionization trail of beta particles traversing a semiconductor.

Radioluminescence

Radioluminescence is the phenomenon by which light is produced in a material by bombardment with ionizing radiation such as alpha particles, beta particles, or gamma rays. Radioluminescence is used as a low level light source for night illumination of instruments or signage. Radioluminescent paint used to be used for clock hands and instrument dials, enabling them to be read in the dark. Radioluminescence is also sometimes seen around high-power radiation sources, such as nuclear reactors and radioisotopes.

Promethium (61Pm) is an artificial element, except in trace quantities as a product of spontaneous fission of 238U and 235U and alpha decay of 151Eu, and thus a standard atomic weight cannot be given. Like all artificial elements, it has no stable isotopes. It was first synthesized in 1945.

Telectronics Pty Ltd was an Australian company best known for its role in developing the pacemaker. It was located in Lane Cove, Sydney. In 1988 the business was acquired by Pacific Dunlop. However, legal claims resulting from the sale of faulty pacemaker electrode leads inherited by the company in acquisition of Cordis Corporation of Miami led to eventual sale of the assets of the company and Pacific Dunlop restructuring itself into Ansell.

An optoelectric nuclear battery is a type of nuclear battery in which nuclear energy is converted into light, which is then used to generate electrical energy. This is accomplished by letting the ionizing radiation emitted by the radioactive isotopes hit a luminescent material, which in turn emits photons that generate electricity upon striking a photovoltaic cell.

The alkali-metal thermal-to-electric converter (AMTEC), originally called the sodium heat engine (SHE) was invented by Joseph T. Kummer and Neill Weber at Ford in 1966, and is described in US Patents 3404036, 3458356, 3535163 and 4049877. It is a thermally regenerative electrochemical device for the direct conversion of heat to electrical energy. It is characterized by high potential efficiencies and no moving parts except for the working fluid, which make it a candidate for space power applications.

Anthony Adducci Inventor and entrepreneur

Anthony J. Adducci was a pioneer of the medical device industry in Minnesota. He is best known for co-founding Cardiac Pacemakers, Inc., the company that manufactured the world's first lithium battery powered artificial pacemaker. The lithium-iodide cell is now the standard cell for pacemakers, having the energy density, low self-discharge, small size and reliability needed.

Biotronik is a privately held multinational biomedical technology company headquartered in Berlin, Germany.

Larry C. Olsen was a pioneer in the commercialization of betavoltaic technology due to his successful work in leading the development of the first commercially available betavoltaic nuclear battery at McDonnell Douglas Corporation in the 1970s.[,] Several hundred of these batteries were fabricated and a large number were used to power implanted heart pacemakers[]. Olsen has published more than 80 articles in the fields of betavoltaics, photovoltaics, thermoelectric materials, and solid state physics. He has also earned several awards for his research, including the R&D 100 Award, presented each year by R&D Magazine to identify the 100 most significant, newly introduced research and development advances in multiple disciplines.

Esther Sans Takeuchi is a materials scientist and chemical engineer, working on energy storage systems and power sources for biomedical devices. She is also a Distinguished Professor at Stony Brook University and a chief scientist at Brookhaven National Laboratory. She holds more than 150 U.S. patents. “The battery was invented once and reinvented over 100 times. I don’t own the patent. The company does. It was called Greatbatch. Now it’s called Integer Corp. When you join a company, you sign over your patent rights to the company.”

Cardiac Pacemakers, Inc.

Cardiac Pacemakers, Inc.(CPI), doing business as Guidant Cardiac Rhythm Management, manufactured implantable cardiac rhythm management devices, such as pacemakers and defibrillators. It also sold insulin pumps controlled by microprocessors and various equipments to regulate heart rhythm. In addition, Cardiac Pacemakers, Inc. developed therapies for the treatment of irregular heartbeats. The company was founded in 1971 and is based in St. Paul, Minnesota. Cardiac Pacemakers, Inc. operates as a subsidiary of Boston Scientific Corporation.

Diamond battery is the name of a nuclear battery concept proposed by the University of Bristol Cabot Institute during their annual lecture held on 25 November 2016 at the Wills Memorial Building. This battery is proposed to run on the radioactivity of waste graphite blocks and would generate small amounts of electricity for thousands of years.

Cyborg data mining is the practice of collecting data produced by an implantable device that monitors bodily processes for commercial interests. As an android is a human-like robot, a cyborg, on the other hand, is an organism whose physiological functioning is aided by or dependent upon a mechanical/electronic device that relies on some sort of feedback.

References

  1. "Nuclear Battery," U.S. Patent 3,706,893 , Larry C. Olsen, Stephen E. Seeman, Bobby I. Griffin and Charles J. Ambrose.
  2. "The Betavoltaic Pacemaker Power Source," WE Matheson, Advances in Pacemaker Technology, M. Schaldach and S. Furman, Editors, Springer-Verlag, 1975, page 401, Proc. Int. Symp. on Advances in Pacemaker Technology Erlagen (1974). doi:10.1007/978-3-642-66187-7_25.
  3. 1 2 "Nuclear-Fueled Cardiac Pacemakers," Fred N. Huffman and John C. Norman, CHEST 65, page 667 - 672 (1974).
  4. 1970 - Tri-City Herald “Man of the Year”. Honor given by the Tri-City Herald of Tri-Cities, WA for leading the development of the Betacel nuclear battery at Donald W. Douglas Laboratories. See page 1 of the Tri-City Herald, January 1, 1971.
  5. "Benefits and Risks of Promethium Battery-Powered Pacemakers," R. Franco and M.L. Smith, Advances in Pacemaker Technology, M. Schaldach and S. Furman, Editors, Springer-Verlag, 1975, page 539, Proc. Int. Symp. on Advances in Pacemaker Technology Erlagen (1974).
  6. Benefit/Risk Analysis of Cardiac Pacemakers Powered by BETACEL Promethium-147 Batteries, T.H. Smith, J. Greenborg and W.E. Matheson, Nuclear Technology 26, May 1975.
  7. "Benefits and Risks of Promethium Battery-Powered Pacemakers," R. Franco and M.L. Smith, Advances in Pacemaker Technology, M. Schaldach and S. Furman, Editors, Springer-Verlag, 1975, page 539, Proc. Int. Symp. on Advances in Pacemaker Technology Erlagen (1974).
  8. "Betacel Nuclear Batteries for Biomedical Applications," L.C. Olsen and S.E Seeman, 8th Intersociety Energy Conversion Engineering Conference, Philadelphia, PA, page 451, August 13–17, 1973.